for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CHF Solutions Inc

CHFS.OQ

Latest Trade

1.49USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1.26

 - 

18.76

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
1.49
Open
--
Volume
--
3M AVG Volume
2.83
Today's High
--
Today's Low
--
52 Week High
18.76
52 Week Low
1.26
Shares Out (MIL)
2.58
Market Cap (MIL)
3.93
Forward P/E
-0.25
Dividend (Yield %)
--

Latest Developments

More

CHF Solutions Inc Announces 53 Percent Increase In Revenues For Second Quarter 2019 Over Previous Year And 38 Percent Increase From Q1 2019

CHF Solutions Reports Q1 Basic And Diluted Loss Per Share Of $11.47

Altium Capital Management, Lp Reports 9.9 Percent Passive Stake In CHF Solutions As Of March 8, 2019 - SEC Filing

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CHF Solutions Inc

CHF Solutions, Inc., formerly Sunshine Heart, Inc., is a medical device company. The Company is focused on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System (Aquadex) is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy. Aquadex is also indicated for extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overloads who have failed diuretic therapy and require hospitalization.

Industry

Medical Equipment & Supplies

Contact Info

12988 Valley View Rd

+1.952.3454200

https://www.chf-solutions.com/

Executive Leadership

John L. Erb

Chairman of the Board, President, Chief Executive Officer

Claudia Drayton

Chief Financial Officer, Secretary

Vitaliy Epshteyn

Vice President of Operations and Engineering

Gordon Weber

Vice President, General Counsel

Carrie Powers

Vice President - Marketing

Key Stats

1.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2017

-442.540

2018

-42.140

2019(E)

-6.020
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.68
Price To Book (MRQ)
0.42
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-199.19
Return on Equity (TTM)
-157.86

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up